MedTrace Logo

Effectiveness of the Universal Prevention Program Super Skills for Life in Schools

NCT06444581 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2024-12-09

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of a 12-session cognitive-behavioral transdiagnostic protocol for Spanish children aged 8 to 12 within an educational context, Super Skills for Life. The program, designed to enhance emotional management and social interaction skills, will be delivered in a group format and supplemented with multimedia materials. The study will compare outcomes between an intervention group and a wait-list control group.

Conditions

  • Social Skills
  • Perfectionism
  • Self Esteem
  • Positive Affect
  • Negative Affect
  • Emotion Regulation
  • Depressive Symptoms
  • Anxiety Symptoms
  • Mood Disorders
  • Emotional Intelligence

Interventions

BEHAVIORAL

Super Skills Schools

Super Skills Structured and manualized intervention with a manual for the therapist and a workbook for the children. The intervention will be administered by Super Skills-trained clinical psychologists. Sessions will take place once a week for twelve weeks, with each session lasting approximately fifty minutes. The program includes emotional education and social skills training. These contents are learned through playful exercises, activities, readings and role-playing. The intervention modality will be face-to-face.

Sponsors & Collaborators

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • Mireia Orgilés Amorós, professor · Miguel Hernadez University of Elche

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2024-05-15
Completion
2025-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06444581 on ClinicalTrials.gov